Publications

Economics of Global Health and Infectious Diseases Unit

2026

  • Abraham P, Lubis IN, Novivanti R, Trianty L, Nisa FA, Kariodimedjo P, Amalia R, Cahyadi RA, Al Qorny TM, Perlambang YA, Permatasari R. The household economic burden of human-only and zoonotic malaria, compared to other causes of acute febrile illness in Indonesia. BMJ Global Health. 2026 Mar 26;11(3). https://doi.org/10.1136/bmjgh-2025-020504
  • Quach A, Mayxay M, Bounvilay L, Thammavong A, Bounkhoun T, Phaiphichit C, Kingkeooudom N, Phangmanixay S, Souvannasing P,  Ashley EA, Nguyen C, Carvalho N*, Russell FM* (*Joint senior) Financial burden of severe childhood illness on households in Lao People’s Democratic Republic: A prospective cohort study. PLOS Global Public Health. 2026; 6(2): e0004783. https://doi.org/10.1371/journal.pgph.0004783
  • Niyibitegeka F, Manirakiza A, Hezagira N, Sinarinzi P, Abraham P, Devine A. Economic burden of malaria in children under the age of five in Burundi. Malar J. 2025;25(1):11. https://doi.org/10.1186/s12936-025-05684-0
  • Dysoley L, Cassidy-Seyoum S, Adhikari B, Dahal A, Solana T, Phoumen N, Srey S, Phalla T,  Vonn P, Engrkruy B, Sovanarath O, Mengkea H, Rathana P, Makara I, Suor B, Heng PK, Heng Y, Khlok H, Pong K, Moeng T, Soviet U, Ravuth R, Bunreth V, Vannak K, Sokhann M, Kimmen K, Dy K, Samol S, Lo K, Sokunthea N, Kry H, Kanha L, Naren L, Oum S, Sovann YK, Channavuth R,  Bunmeng C, Hughes J, Brindle H, Hu Y, Peng S, Mardi P, Chanry I, Preap S, Heoy S, Sabawoon F, Sokha T, Ringwald P, Lynch CA, Price RN, Tripura R, von Seidlein L, Devine A, Thriemer K. Moving towards high-dose primaquine or tafenoquine for P. vivax treatment in Cambodia: A meeting report from dissemination of results of the EFFORT trial to stakeholders. Malaria Journal. 2026; 25:2, 1-9. https://doi.org/10.1186/s12936-025-05691-1
  • Carlin JB, Marcato AJ, Wang Y, Moss R, Carville KS, Chen X, Oliver VL, Spirkoska V, Campbell PT, Price DJ, Carvalho N. Cost-effectiveness of immunising interventions to reduce respiratory syncytial virus disease burden in infants in Australia. PharmacoEconomics. 2026. https://doi.org/10.1007/s40273-026-01601-8
  • Cheng Q, Watts C, Al Adawiyah R, Guy R, Ong JJ, Bradshaw CS, Wiseman V. Cost of illness of Mycoplasma genitalium in Australia: an incidence-based approach incorporating resistance-guided therapy. Sci Rep. 2026. https://doi.org/10.1038/s41598-026-36992-3
  • Carvalho N, Watts E, Oliver V L, Clark A, Ozturk MH, Akauola S, Whelan C, Naseri T, Jenkins K, Mikkelsen-Lopez I, Lam KFK, Rabanal R, McLeod R, Jit M, & Russell FM. Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study. PLOS Medicine. 2026; 23(2), e1004604. https://doi.org/10.1371/journal.pmed.1004604
  • Boujaoude MA, Devlin N, Bourke M, Dalziel K, Carvalho N. What Role Does Equity Play in Australia’s Health Technology Assessment Processes? A Review of the Pharmaceutical Benefits Advisory Committee Recommendations Regarding Vaccines. Value in Health Regional Issues. 2025; 51. https://doi.org/10.1016/j.vhri.2025.101559
  • Boujaoude MA, Devlin N, Doran T, Hurley J, Cookson R, on behalf of the Exploring Distributional Equity in health (EDE) group. Strengthening Methods and International Evidence on Health Inequality Aversion. Value in Health. 2026. https://doi.org/10.1016/j.jval.2025.11.006
  • Akpan E, Ku Abd Rahim KN, Devine A, Sharifa Ezat WP, Abraham P, Ali FZ, Lee SW, Tanaka T, Ghazali IM, Carvalho N. Health and economic burden of COVID-19 in Malaysia between January 2020 and December 2022. Public Health. 2026 Jan;250:105992. doi: 10.1016/j.puhe.2025.105992

2025

  • Wirawan GBS, Kelly-Hanku A, Adawiyah RA, Wolter A, Hegarty B, Yuniar Y, Ridwan R, Januraga PP, Lestary H, Wulandari LPL. Public and private antenatal care access and utilisation as determinants of triple antenatal testing for HIV, syphilis, and HBV: Evidence from the Indonesian Health Survey. Women and Birth. 2026;39(1):102153. doi:10.1016/j.wombi.2025.102153.
  • Peixoto HM, Bastos Gottinb LL, de Brito-Sousac JD, Sampaio V, Daumerie PG, Jambert E, Monteiroc W, Lacerdac MVG, Devine A. The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health System. The Lancet Regional Health Americas. 2025; 51. https://doi.org/10.1016/j.lana.2025.101216
  • Setiawan E, Devine A, Prameswary AD, Baird JK, Price R, Thriemer K. Malaria morbidity, mortality and associated costs in Indonesia: analysis of the National Health Insurance claim dataset. BMJ Global Health. 2025; 10. doi: 10.1136/bmjgh-2024-018255
  • Rae JD, Devine A, Patekkham C, Thu AM, Delmas G, Parker DM, Maude RJ, Wiladphaingern J, Kajeechiwa L, Thwin MM, Tun SW, Simpson J & Nosten FH. The impact of mass screening and treatment interventions on malaria incidence and prevalence: a retrospective analysis of a malaria elimination programme in eastern Myanmar, and systematic review and meta-analysis. Malaria Journal. 2025.  https://doi.org/10.1186/s12936-025-05392-9
  • Lim C, Maung Swea MM, Devine A, Oakleye T, Champline K, Oa PS, Sarmentoe N, Da Costa Barretof I, Givneye RC, Yane J,  Francise JR, Cooper BS. Cost-effectiveness of maintaining an active hospital microbiology laboratory service in Timor-Leste. The Lancet Regional Health Southeast Asia. 2025; 24.  https://doi.org/10.1186/s12936-025-05392-9
  • Rae JD, Chen W, Diarra S, Nghiem N, Chisholm RH, Tran-Duy A, Shearer F & Devine A. Web-based models to inform health policy: A scoping review. Health Research Policy and Systems. 2025; 23. https://doi.org/10.1186/s12961-025-01367-z
  • SCOPE Study Group. High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of Plasmodium vivax malaria in Indonesia and Papua New Guinea: the SCOPE implementation study protocol. BMC Infectious Diseases. 2025; 25. https://doi.org/10.1186/s12879-025-11109-9
  • Le TP, Conway E, Akpan E, Abell IR, Abraham P, Baker CM, et al. (2025). Health impact and cost-effectiveness of COVID-19 booster vaccination strategies in the early post-Omicron era: a dynamic modelling study. BMJ Global Health. 10:e016096. https://doi.org/10.1136/bmjgh-2024-016096
  • Atkinson SH, Suchdev PS, Bode M, …, Carvalho N, …, Pasricha SR. (2025). Getting back on track to meet global anaemia reduction targets: a Lancet Haematology Commission. Lancet Haematol. 2025 Sep;12(9):e717-e767. doi: 10.1016/S2352-3026(25)00146-2
  • Bode M, Carvalho N, Leung S, Pasricha SR. (2025). Progress towards global nutrition targets and future directions. Lancet. 406(10505):808. doi: 10.1016/S0140-6736(25)01460-6.
  • Blythe R, Carvalho N, Holloway-Brown J, Leung S, Oliver VL, Wang Y, Glover-Wright C, Pasricha SR, Bode M. (2025). Cost-effective targets for anaemia reduction in 191 countries: a modelling study. Lancet Haematol. 12(9):e674-e683. doi: 10.1016/S2352-3026(25)00168-1
  • Oliver VL, Wang Y, Leung S, Blythe R, Glover-Wright C, Holloway-Brown J, Bode M, Pasricha SR, Carvalho N. (2025). Estimated unit costs of anaemia interventions for women of reproductive age in 193 UN member states: a costing study. Lancet Haematol. 12(9):e684-e693. doi: 10.1016/S2352-3026(25)00171-1
  • Prang, KH., Rahman, A.Q., Verbunt, E. …Carvalho N,…et al. (2025). Feasibility and Acceptability of Intravenous Iron for Anaemia in Pregnancy in Bangladesh: A Demonstration Project Protocol. Glob Implement Res Appl. https://doi.org/10.1007/s43477-025-00176-4
  • Abraham P, McMullin C, William T, Rajahram GS, Jelip J, ... Devine A. (2025). Household costs associated with zoonotic Plasmodium knowlesi, P. falciparum, P. vivax and P. malariae infections in Sabah, Malaysia. PLOS Neglected Tropical Diseases 19(4): e0012180. https://doi.org/10.1371/journal.pntd.0012180
  • Boujaoude MA, Dalziel K, Cookson R, Devlin N, Carvalho N. (2024). Aversion to income, ethnic, and geographic related health inequality: Evidence from Australia. Social Science and Medicine. https://doi.org/10.1016/j.socscimed.2024.117495
  • At Thobari J, Watts E, Carvalho N, Haposan JH, Clark A, et al. (2025). Cost effectiveness analysis of rotavirus vaccination in Indonesia. Vaccine; 43 (Part 2):126478. https://doi.org/10.1016/j.vaccine.2024.126478

2024

  • Akpan E, Thean LJ, Baskota R, Mani J, Mow M, Kama M, Tuicakau M, Kado J, Romani L, Kaldor J, Engelman D, Steer A, Carvalho N. (2024). Costs of primary healthcare presentations and hospital admissions for scabies and related skin infections in Fiji, 2018–2019. PLOS Global Public Health 4(10): e0003706. https://doi.org/10.1371/journal.pgph.0003706
  • Chang J, Zhu S, Zhang Y, Carvalho N, et al. (2024). Determinants of parental demand of human papillomavirus vaccination for adolescent daughters in China: contingent valuation survey. Int J Health Plann Mgmt. 1-26. doi.org/10.1002/hpm.3818
  • Niyibitegeka F, Russell FM, Jit M, Carvalho N. (2024). Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate Vaccination. Vaccines 12(7):767. doi:10.3390/vaccines12070767
  • Setiawan E, Cassidy-Seyoum SA, Ley-Thriemer K, Carvalho N, Devine A. (2024). A systematic review of methods for estimating productivity losses due to illness or caregiving in low- and middle-income countries. Pharmacoeconomics 42(8):865-877. doi: 10.1007/s40273-024-01402-x
  • Rwebembera J, Ngadire E, Carvalho N. et al. (2024). Intramuscular versus Enteral Penicillin Prophylaxis to Prevent Progression of Rheumatic Heart Disease: Study Protocol for a non-inferiority randomized trial (the GOALIE trial). Am Heart Journal 275: 74-85. doi.org/10.1016/j.ahj.2024.05.012
  • Anwar MN, Smith L, Devine A, Mehra S, Walker CR, Ivory E, ... Hickson RI. (2024). Mathematical models of Plasmodium vivax transmission: A scoping review. PLOS COMPUTATIONAL BIOLOGY, 20(3), pp. 26-. doi:10.1371/journal.pcbi.1011931
  • Wang Y, Giles ML & Carvalho N. (2024). Potential Cost-Effectiveness of Maternal Influenza Immunisation in Low-Income Countries: An Explorative Modelling Study and Value of Information Analysis to Guide Future Clinical Research. Vaccines, 12(3), doi:10.3390/vaccines12030232
  • Xiong X, Carvalho N, Huang L, Chen G, Jones R, Devlin N, ... Dalziel K. (2024). Psychometric Properties of Child Health Utility 9D (CHU9D) Proxy Version Administered to Parents and Caregivers of Children Aged 2-4 Years Compared with Pediatric Quality of Life Inventory™ (PedsQL). PHARMACOECONOMICS, pp. 15-. doi:10.1007/s40273-024-01355-1
  • Price DJ, Nekkab N, Monteiro WM, Villela DA, Simpson JA, Lacerda MV, ... Devin A. (2024). Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model. PLOS MEDICINE, 21(1), pp. 17-. doi:10.1371/journal.pmed.1004255

2023

  • Walker C, Hickson R, Chang E, Ngor P, Sovannaroth S, Simpson J, ... Devine A. (2023). A model for malaria treatment evaluation in the presence of multiple species. EPIDEMICS, 44 pp. 9-. doi:10.1016/j.epidem.2023.100687
  • Neppelenbroek NJ, de Wit GA, Dalziel K, Devlin N & Carvalho N. (2023). Use of Utility and Disability Weights in Economic Evaluation of Pediatric Vaccines. Value Health, 26(7), pp. 1098-1106. doi:10.1016/j.jval.2023.03.005
  • Xiong X, Dalziel K, Huang L, Mulhern B & Carvalho N. (2023). How do common conditions impact health-related quality of life for children? Providing guidance for validating pediatric preference-based measures. Health and Quality of Life Outcomes, 21(1), pp. 11-. doi:10.1186/s12955-023-02091-4
  • Tellioglu N, Chisholm RH, Campbell PT, Collinson S, Timothy J, Kollie K, Zayzay S, Devine A, McVernon J, Marks M, & Geard N. (2023). Modelling mass drug administration strategies for reducing scabies burden in Monrovia, Liberia. Epidemiology and infection, 151, e153. https://doi.org/10.1017/S0950268823001310
  • Xu X, Chow EPF, Fairley CK, Chen M, Aguirre I, Goller J, Hocking J, Carvalho N, Zhang L, & Ong JJ (2023). Determinants and prediction of Chlamydia trachomatis re-testing and re-infection within 1 year among heterosexuals with chlamydia attending a sexual health clinic. Frontiers in public health, 10, 1031372. https://doi.org/10.3389/fpubh.2022.1031372
  • Fernando-Canavan L, Abraham P, Devlin N, Duy-Tran A. (2023) Health-related quality of life in patients with extremity bone sarcoma after surgical treatment: a systematic review. Qual Life Res. doi:10.1007/s11136-023-03554-3
  • Alexander M, Collins I, Abraham P, Underhill C, Harris S, Torres J, Sharma S, Solomon B, Tran-Duy A, & Burbury K. (2023). Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial. Internal medicine journal, 53(12), 2346–2349. doi:10.1111/imj.16292

2022

  • Goller JL, Coombe J, Temple-Smith M, Bittleston H, Sanci L, Guy R, Fairley C, Regan D, Carvalho N, ... Hocking J S. (2022). Management of Chlamydia Cases in Australia (MoCCA): protocol for a non-randomised implementation and feasibility trial. BMJ OPEN, 12(12), pp. 9-. doi:10.1136/bmjopen-2022-067488
  • Akpan E, Hossain SJ, Devine A, Braat S, Hasan MI, Tipu SMMU, Bhuiyan MSA, Hamadani JD, Biggs BA, Pasricha SR & Carvalho N. (2022). Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial. The American journal of clinical nutrition, 116(5), 1303–1313. doi:10.1093/ajcn/nqac225
  • Carvalho N, Sousa TV, Mizdrak A, Jones A, Wilson N, & Blakely T.(2022). Comparing health gains, costs and cost-effectiveness of 100s of interventions in Australia and New Zealand: an online interactive league table. Population health metrics, 20(1), 17. doi:10.1186/s12963-022-00294-3
  • Marthias, T., McPake, B., Carvalho, N., Millett, C., Anindya, K., Saputri, N. S., ... Lee, J. T. (2022). Associations between Indonesia's national health insurance, effective coverage in maternal health and neonatal mortality: a multilevel interrupted time-series analysis 2000-2017. Journal of Epidemiology and Community Health, 76(12), pp. 999-1010. doi:10.1136/jech-2021-217213
  • Thean, L. J., Romani, L., Engelman, D., Wand, H., Jenney, A., Mani, J., Paka, J., Cua, T., Taole, S., Silai, M., Ashwini, K., Sahukhan, A., Kama, M., Tuicakau, M., Kado, J., Parnaby, M., Carvalho, N., Whitfeld, M., Kaldor, J., & Steer, A. C. (2022). Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020. The Lancet regional health. Western Pacific, 22, 100433 doi:10.1016/j.lanwpc.2022.100433
  • Mow, M., Thean, L. J., Parnaby, M., Mani, J., Rafai, E., Sahukhan, A., ... Carvalho, N. (2022). Costs of mass drug administration for scabies in Fiji. Plos Neglected Tropical Diseases, 16(2), pp. 13-. doi:10.1371/journal.pntd.0010147
  • At Thobari, J., Sutarman, Mulyadi, A. W., Watts, E., Carvalho, N., Debellut, F., ... Bines, J. E. (2022). Direct and indirect costs of acute diarrhea in children under five years of age in Indonesia: Health facilities and community survey. Lancet Regional Health-Western Pacific, 19 pp. 13-. doi:10.1016/j.lanwpc.2021.100333
  • Lake, S. J., Engelman, D., Sokana, O., Nasi, T., Boara, D., Marks, M., ... Carvalho, N. (2022). Health-related quality of life impact of scabies in the Solomon Islands. Transactions of the Royal Society of Tropical Medicine and Hygiene, 116(2), pp. 148-156. doi:10.1093/trstmh/trab096
  • Ferdinand, A., Nightingale, C., Carvalho, N., Hocking, J., Ludwick, T., Creagh, N., ... McEwan, C. (2022). Evaluation of COVID-19 rapid antigen testing at a Victorian large-scale construction project.
  • Dale, K. D., Abayawardana, M. J., McBryde, E. S., Trauer, J. M. & Carvalho, N. (2022). Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting. American Journal of Epidemiology, 191(2), pp. 255-270. doi:10.1093/aje/kwab150
  • Xiong, X., Dalziel, K., Carvalho, N., Xu, R. & Huang, L. (2022). Association between 24-hour movement behaviors and health-related quality of life in children. Quality of Life Research, 31(1), pp. 231-240. doi:10.1007/s11136-021-02901-6
  • Rae, J. D., Nosten, S., Kajeechiwa, L., Wiladphaingern, J., Parker, D. M., Landier, J., Thu, A. M., Dah, H., Be, A., Cho, W. C., Paw, K., Paw, E. S., Shee, P. B., Poe, C., Nu, C., Nyaw, B., Simpson, J. A., Devine, A., Maude, R. J., Moo, K. L., … Nosten, F. H. (2022). Surveillance to achieve malaria elimination in eastern Myanmar: a 7-year observational study. Malaria journal, 21(1), 175 doi:10.1186/s12936-022-04175-w
  • Brito-Sousa, J. D., Peixoto, H. M., Devine, A., Silva-Neto, A. V., Balieiro, P. C., Sampaio, V. S., ... Monteiro, W. M. (2022). Real-life quantitative G6PD screening in Plasmodium vivax patients in the Brazilian Amazon: A cost-effectiveness analysis. Plos Neglected Tropical Diseases, 16(3), pp. 12-. doi:10.1371/journal.pntd.0010325
  • Devine, A., Xiong, X., Gottlieb, S. L., de Mello, M. B., Fairley, C. K. & Ong, J. J. (2022). Health-related quality of life in individuals with genital herpes: a systematic review. Health and Quality of Life Outcomes, 20(1), pp. 16-. doi:10.1186/s12955-022-01934-w
  • Lim, M., Devine, A., Gray, R. T., Kwon, J. A., Hutchinson, J. L. & Ong, J. J. (2022). Lifetime cost of HIV management in Australia: an economic model†. Sexual Health, 19(6), pp. 517-524. doi:10.1071/SH21250
  • Abraham, P., Manski-Nankervis, J. A., Biezen, R., Hallinan, C. M., Gibney, K. B., Sanci, L., & Ride, J. (2022). Costing of an Australian general practice COVID-19 drive-through testing and respiratory clinic. BMC primary care, 23(1), 58. doi:10.1186/s12875-022-01664-4

2021

  • Carvalho, N., Abraham, P., Devine, A., Akpan, E. & McPake, B. (2021). The economic burden of COVID-19 on healthcare services in Malaysia.
  • Blakely, T., Thompson, J., Bablani, L., Andersen, P., Ouakrim, D. A., Carvalho, N., ... Stevenson, M. (2021). Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia. JAMA Health Forum, 2(7), pp. 13-. doi:10.1001/jamahealthforum.2021.1749
  • Thean, L. J., Romani, L., Engelman, D., Wand, H., Jenney, A., Mani, J., ... Steer, A. C. (2022). Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020. Lancet Regional Health-Western Pacific, 22 pp. 9-. doi:10.1016/j.lanwpc.2022.100433
  • Anindya, K., Marthias, T., Vellakkal, S., Carvalho, N., Atun, R., Morgan, A., ... Lee, J. T. (2021). Socioeconomic inequalities in effective service coverage for reproductive, maternal, newborn, and child health: a comparative analysis of 39 low-income and middle-income countries. Eclinicalmedicine , 40 pp. 10-. doi:10.1016/j.eclinm.2021.101103
  • Xiong, X., Huang, L., Carvalho, N. & Dalziel, K. (2021). Physical activity is critical for children’s quality of life.
  • Vu, M., Carvalho, N., Clarke, P. M., Buchbinder, R. & An, T. (2021). Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis. Journal of Rheumatology, 48(8), pp. 1221-1229. doi:10.3899/jrheum.200231
  • Blakely, A., Thompson, J., Bablani, L., Andersen, P., Ait Ouakrim, D., Carvalho, N., ... STEVENSON, M. (2021). We need to talk about elimination vs suppression in Australia again.
  • Abraham, P., Bablani, L., Carvalho, N. & Blakely, A. (2021). Yes, lockdowns are costly. But the alternatives are worse.
  • Thompson, J., Carvalho, N. & Blakely, T. (2021). The probability of the 6-week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS-CoV-2. Medical Journal of Australia, 215(2), pp. 96-+. doi:10.5694/mja2.51157
  • Thean, L. J., Romani, L., Engelman, D., Jenney, A., Wand, H., Mani, J., ... Steer, A. C. (2021). Prospective Surveillance of Primary Healthcare Presentations for Scabies and Bacterial Skin Infections in Fiji, 2018-2019. American Journal of Tropical Medicine and Hygiene, 105(1), pp. 230-237. doi:10.4269/ajtmh.20-1459
  • Rae, J. D., Landier, J., Simpson, J. A., Proux, S., Devine, A., Maude, R. J., ... Nosten, F. H. (2021). Longitudinal trends in malaria testing rates in the face of elimination in eastern Myanmar: a 7-year observational study. BMC Public Health, 21(1), pp. 12-. doi:10.1186/s12889-021-11749-x
  • Agius, P., Simpson, J., Dini, S., Gething, P., Devine, A. & Fowkes, F. (2021). Applying novel multi-disciplinary methodologies to accelerate malaria elimination. International Journal of Epidemiology, 50 pp. 8-8. doi:10.1093/ije/dyab168.014
  • Devine, A., Battle, K. E., Meagher, N., Howes, R. E., Dini, S., Gething, P. W., ... Lubell, Y. (2021). Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. PLOS Medicine, 18(6), pp. 20-. doi:10.1371/journal.pmed.1003614
  • Devine, A., Vahanian, A., Sawadogo, B., Zan, S., Bocoum, F. Y., Kelly, H., ... Mayaud, P. (2021). Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study. PLOS One, 16(3), pp. 16-. doi:10.1371/journal.pone.0248832
  • Bierhoff, M., Angkurawaranon, C., Rijken, M. J., Sriprawa, K., Kobphan, P., Nosten, F. N., ... Devine, A. (2021). Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Pregnancy and Childbirth, 21(1), pp. 12-. doi:10.1186/s12884-021-03612-z
  • Lim, M., Devine, A., Gray, R., Kwon, J., Hutchinson, J. & Ong, J. (2021). LIFETIME COST OF HIV MANAGEMENT IN AUSTRALIA: A MODELLING STUDY. Sexual Health, 18(4), pp. VIII-VIII.

2020

  • Devine, A., Howes, R.E., Price, D.J., Moore, K.A., Ley, B., Simpson, J.A., Dittrich, S., Price, R.N. 2020. Cost-effectiveness analysis of sex-stratified Plasmodium vivax treatment strategies using available G6PD diagnostics to accelerate access to radical cure. American Journal of Tropical Medicine and Hygiene, 103(1), pp.394-403. doi:10.4269/ajtmh.19-0943
  • Carvalho, N., Hoque, M. E., Oliver, V. L., Byrne, A., Kermode, M., Lambert, P., ... Morgan, A. (2020). Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings. BMC Medicine, 18(1), pp. 18-. doi:10.1186/s12916-020-01658-y
  • Bablani, L., Thompson, J., Andersen, P., Katar, A., Abraham, P., Boujaoude, M., ... Blakely, A. (2020). Determining optimal COVID-19 policy responses for Pakistan and Khyber Pakhtunkhwa.
  • Bablani, L., Thompson, J., Andersen, P., Katar, A., Abraham, P., Boujaoude, M., ... Blakely, A. (2020). Determining optimal COVID-19 policy responses for Armenia.
  • Thean, L. J., Jenney, A., Engelman, D., Romani, L., Wand, H., Mudaliar, J., ... Steer, A. C. (2020). Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019. PLOS Neglected Tropical Diseases, 14(12), pp. 14-. doi:10.1371/journal.pntd.0008887

2019 and earlier

  • Devine, A., Pasaribu, A., Teferi, T., Huong-Thu, P., Contantia, F., Thuy-Nhien, N., ... Lubell, Y. (2018). ECONOMIC COSTS OF PLASMODIUM VIVAX EPISODES: A MULTI-COUNTRY COMPARATIVE ANALYSIS USING PRIMARY TRIAL DATA. American Journal of Tropical Medicine and Hygiene, LA, New Orleans, 99(4), pp. 427-427.
  • Carvalho, N., Petrie, D., Chen, L., Salomon, J. A. & Clarke, P. (2019). The impact of Medicare part D on income-related inequality in pharmaceutical expenditure. International Journal for Equity in Health, 18 pp. 11-. doi:10.1186/s12939-019-0955-9
  • Devine, A., Pasaribu, A., Teferi, T., Huong-Thu, P., Contantia, F., Thuy-Nhien, N., ... Lubell, Y. (2018). ECONOMIC COSTS OF PLASMODIUM VIVAX EPISODES: A MULTI-COUNTRY COMPARATIVE ANALYSIS USING PRIMARY TRIAL DATA. American Journal of Tropical Medicine and Hygiene, LA, New Orleans, 99(4), pp. 427-427.
  • Carvalho, N., Jit, M., Cox, S., Yoong, J. & Hutubessy, R. C. (2018). Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework. Pharmacoeconomics, 36(1), pp. 79-90. doi:10.1007/s40273-017-0569-2
  • Boujaoude, M., Mirelman, A. J., Dalziel, K. & Carvalho, N. (2018). Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries. Cost-Effectiveness and Resource Allocation, 16 pp. 14-. doi:10.1186/s12962-018-0102-2
  • Hua, X., Carvalho, N., Tew, M., Huang, E. S., Herman, W. H. & Clarke, P. (2016). Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013. JAMA-Journal of the American Medical Association, 315(13), pp. 1400-1402. doi:10.1001/jama.2016.0126
  • Allen, K. J., Panjari, M., Koplin, J. J., Ponsonby, A., Vuillermin, P., Gurrin, L. C., ... Dharmage, S. C. (2015). VITALITY trial: protocol for a randomised controlled trial to establish the role of postnatal vitamin D supplementation in infant immune health. BMJ Open, 5(12), pp. 8-. doi:10.1136/bmjopen-2015-009377